Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
Joe Leach, MD, discusses how comprehensive biomarker testing has impacted treatment selection for patients with small cell lung cancer. Joe Leach, MD, medical oncologist, associate medical director ...
Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...
Lung cancer, encompassing both small cell and non-small cell types and affecting ... They make their way to us when a mass ...
A researcher at Stanford University School of Medicine has been diagnosed with stage 4 lung cancer, even though he has never ...
Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...
Stanford University medical professor Dr. Bryant Lin was diagnosed with stage IV lung cancer despite never smoking. Now, he's ...
An X-ray at a polyclinic revealed ... followed by genetic testing on a cancer-stricken lymph node to check for mutations causing non-small cell lung cancer (NSCLC). The test revealed that Ms ...
The phase 3 trial found adding the TIGIT candidate tiragolumab to Roche's approved checkpoint inhibitor had no effect on overall survival (OS) in non-small cell lung cancer (NSCLC). Investigators ...
The 2024 American Lung Association's "State of Lung Cancer" report, released on Nov. 19, reveals that lung cancer is the most lethal cancer in Florida. The more localized state report shows only a ...
Why don’t you get a chest X-ray ... kind of rare and maybe make up a small portion,” she said. “And then there are mutations that cause lung cancer, and we are also seeing a really ...